Chiara Castrignano, Federica Di Scipio, Francesco Franco, Barbara Mognetti, & Giovanni Nicolao Berta. (2023). Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG.
Style de citation Chicago (17e éd.)Chiara Castrignano, Federica Di Scipio, Francesco Franco, Barbara Mognetti, et Giovanni Nicolao Berta. Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG, 2023.
Style de citation MLA (9e éd.)Chiara Castrignano, et al. Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG, 2023.
Attention : ces citations peuvent ne pas être correctes à 100%.